US pharmaceutical giant Pfizer has announced a deal to make its prospective antiviral Covid-19 pill available more cheaply in the world’s least-wealthy countries.
Pfizer will allow generic manufacturers to supply its promising Paxlovid pill to 95 low-and middle-income nations covering about 53% of the world’s population, the company said in a statement on Tuesday.
Under the licensing agreement deal struck with the global Medicines Patent Pool (MPP), Pfizer — which also produces one of the most
Read more on theguardian.com